Status:

NOT_YET_RECRUITING

Impact of Virtual Reality on Patient Pain During Lower Limb Revascularization Via Endovascular Surgery Under Local Anesthesia With Sedation

Lead Sponsor:

Poitiers University Hospital

Conditions:

Peripheral Arterial Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The prevalence of peripheral arterial disease (PAD) increases with age In addition to medical treatment, endovascular procedures can be performed, depending on the stage of the disease, to prevent com...

Detailed Description

The prevalence of peripheral arterial disease (PAD) increases with age. In high-income countries, it is 5% between the ages of 45 and 49, and 18% after the age of 85. In France, nearly 1 million peopl...

Eligibility Criteria

Inclusion

  • Patient suffering from PAD, scheduled to undergo endovascular surgery for lower limb revascularization under local anesthesia combined with sedation.
  • Age ≥ 18 years.
  • Patient who understands and speaks French.
  • Patient covered by social security or covered through a third party.
  • Free subject, without guardianship, curatorship, or subordination.
  • Patient who has given their free and informed consent.

Exclusion

  • Patients with contraindications to VR headsets (mono- or binocular blindness, epilepsy, migraines, psychiatric disorders, pacemakers, hearing aids, defibrillators, recent injuries to the eyes, face, or scalp that prevent comfortable use of the headsets, etc.).
  • Patients with suspected intolerance to VR headsets (sensitivity to motion sickness in cars, history of balance or eye disorders, etc.);
  • Previous bad experience with VR headsets;
  • Patients undergoing local regional anesthesia (LRA);
  • Persons requiring enhanced protection, namely persons deprived of their liberty by judicial or administrative decision, pregnant women, and finally patients in life-threatening situations.

Key Trial Info

Start Date :

October 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 15 2027

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT07181434

Start Date

October 15 2025

End Date

April 15 2027

Last Update

September 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

C.H.U. Poitiers

Poitiers, France, 86000